AVAI BIO, INC.
AVAIdata completeness 75%8 fiscal years on fileData notes: no data for concept 'incomeTaxExpense'
i. The business — what you’d actually own
| Figure | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 |
|---|---|---|---|---|---|
| Revenue | — | $276,3241 | — | — | — |
| Net income | −$126,5212 | −$348,9333 | −$2.13M4 | −$1.14M5 | −$1.75M5 |
| Operating cash flow | $535,0086 | −$54,4577 | −$1.32M8 | −$1.16M9 | −$1.01M9 |
| Capital expenditure | — | — | — | — | — |
| Free cash flow (derived) | — | — | — | — | — |
| Total debt | $99,00010 | $99,00010 | — | $142,52011 | $24,91812 |
| Cash & equivalents | $33,28913 | $107,47214 | $28115 | $81,05316 | $23,14516 |
| Diluted shares | 26.3M | 38.5M | 86.5M | 128.1M | 138.0M |
Superscripts are receipts. Each links to the SEC filing the number came from (full list at the bottom).
ii. Your slice — ownership made literal
If you owned
shares
Net assets behind them
−$0.2
your share of equity
Profit it earned you last year
−$0.13
Free cash flow it threw off
—
Debt you’d be carrying
$0
10 shares is a claim on −$0.2 of net worth that earned you −$0.13 last year, against $0 of debt.
iii. Is this a good business?
Moat signal · return on equity
— avg · 5y
Not enough data in the filings for a return-on-capital reading.
seeing a moat in the numbers →Management signal · capital allocation
+424% shares · 5y
Share count is up 424% over 5 years — owners have been diluted. Worth asking what they got for it. Total debt has fallen 75% — deleveraging.
reading capital allocation →Signals, not verdicts — read from the filings above. Numbers don’t prove a moat; they show its footprint. You decide.
iv. What it’s worth — engine v0.1.0
DCF · Growth Exit 10Y
not applicable
only 0 years of FCF (need ≥3) — model not applicable
DCF · Growth Exit 5Y
not applicable
only 0 years of FCF (need ≥3) — model not applicable
Earnings Power Value
not applicable
normalized (5y-median) earnings non-positive — EPV undefined
Graham Number
not applicable
diluted EPS missing or non-positive — Graham Number undefined
Different models answer different questions — which to trust when →
Sources — the receipts
- 10-K/A · period ending 2023-03-31 · accession 0001740797-25-000017 (Revenues)
- 10-K/A · period ending 2022-03-31 · accession 0001740797-23-000051 (NetIncomeLoss)
- 10-K/A · period ending 2023-03-31 · accession 0001740797-25-000017 (NetIncomeLoss)
- 10-K · period ending 2024-03-31 · accession 0001740797-25-000038 (NetIncomeLoss)
- 10-K · period ending 2025-03-31 · accession 0001740797-26-000017 (NetIncomeLoss)
- 10-K/A · period ending 2022-03-31 · accession 0001740797-23-000051 (NetCashProvidedByUsedInOperatingActivities)
- 10-K/A · period ending 2023-03-31 · accession 0001740797-25-000017 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2024-03-31 · accession 0001740797-25-000038 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2025-03-31 · accession 0001740797-26-000017 (NetCashProvidedByUsedInOperatingActivities)
- 10-K/A · period ending 2022-03-31 · accession 0001740797-23-000051 (LongTermDebtCurrent)
- 10-K · period ending 2025-03-31 · accession 0001740797-25-000038 (LongTermDebtCurrent)
- 10-K · period ending 2026-03-31 · accession 0001740797-26-000017 (LongTermDebtCurrent)
- 10-K/A · period ending 2022-03-31 · accession 0001740797-23-000051 (CashAndCashEquivalentsAtCarryingValue)
- 10-K/A · period ending 2023-03-31 · accession 0001740797-25-000017 (CashAndCashEquivalentsAtCarryingValue)
- 10-K · period ending 2024-03-31 · accession 0001740797-25-000038 (CashAndCashEquivalentsAtCarryingValue)
- 10-K · period ending 2025-03-31 · accession 0001740797-26-000017 (CashAndCashEquivalentsAtCarryingValue)